Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of Chronic Subdural Hematoma by Corticosteroids
NCT02650609Phase 3Completed
- Sponsor
- CHU Rennes
- Start
- Jun 2016
- Primary completion
- Mar 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of methylprednisolone in chronic subdural hematoma (CSDH), sponsored by CHU Rennes. Started Jun 2016; status: completed.
02
Drugs
methylprednisolone
03
Conditions
chronic subdural hematoma (CSDH)
Beyond the preview
Go deeper on NCT02650609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02650609.